Stay updated on Venetoclax and Dinaciclib in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Dinaciclib in AML Clinical Trial page.

Latest updates to the Venetoclax and Dinaciclib in AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new NIH grant/contract reference was added to the study identifiers to reflect funding attribution. The page revision label was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a page version update. No substantive study content or data appears to be changed.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4 on the page, representing a minor version update to the ClinicalTrials.gov entry. No study data or user-facing content appears to be affected.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page revision indicator was updated from v3.6.2 to v3.6.3, signaling a minor update to the ClinicalTrials.gov study page.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing Revision: v3.6.0. This indicates a recent site release.SummaryDifference0.0%

- Check91 days agoChange DetectedThe study page now states that no participants are being recruited and adds new help/navigation sections such as How to Read a Study Record, Common Questions, and How to Join a Study, along with an Intervention/Treatment heading. The revision tag was updated to v3.6.0 and the older v3.5.5 tag was removed.SummaryDifference0.5%

Stay in the know with updates to Venetoclax and Dinaciclib in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Dinaciclib in AML Clinical Trial page.